Puma Biotechnology Sets Q2 Earnings Date: Key Financial Updates Coming August 7 - Stock Titan
7 hours ago • Google News
Puma Biotechnology Inc (PBYI)
US$ 3.044.47%
Price Chart
Key Statistics
Market Cap
$ 171.25M
P/E Ratio
4.42
Revenue (TTM)
$ 232.71M
Volume
432.84K
52W High
$ 4.13
52W Low
$ 2.23
Dividend Yield
0.00%
Beta
1.28
Technicals
50-Day MA
3.4142
200-Day MA
3.1134
52 Week High
4.13
52 Week Low
2.225
About PBYI
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
Employees
172
Headquarters
Los Angeles, CA
CEO
Mr. Alan H. Auerbach
Latest News
Insider Sale: Director at $PBYI Sells 27,000 Shares - Quiver Quantitative
2 days ago • Google News
PBYI Stock Analysis and Forecast - Consistent high-performance stocks - Autocar Professional
7 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg